| Malvika Sagar, MD | |
|
1901 Sw H K Dodgen Loop, Temple, TX 76502-1814 | |
| (610) 447-6680 | |
| Not Available |
| Full Name | Malvika Sagar |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Pulmonology |
| Location | 1901 Sw H K Dodgen Loop, Temple, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164660304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MT-192448 (Pennsylvania) | Secondary |
| 2080P0214X | Pediatrics - Pediatric Pulmonology | P0485 (Texas) | Primary |
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.
The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.
Levels of adherence to the UK's test, trace, and isolate system and understanding of the main symptoms of covid-19 are low, particularly among men, younger age groups, people with a dependent child in the home, key workers, and those experiencing greater financial hardship, finds an analysis of online survey data published by The BMJ today.
What if doctors could not only diagnose a COVID-19 infection but identify which patients are at the greatest risk of death before any major complications arise?
› Verified 2 days ago
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.
The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.
Levels of adherence to the UK's test, trace, and isolate system and understanding of the main symptoms of covid-19 are low, particularly among men, younger age groups, people with a dependent child in the home, key workers, and those experiencing greater financial hardship, finds an analysis of online survey data published by The BMJ today.
What if doctors could not only diagnose a COVID-19 infection but identify which patients are at the greatest risk of death before any major complications arise?
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Malvika Sagar, MD Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Malvika Sagar, MD 1901 Sw H K Dodgen Loop, Temple, TX 76502-1814 Ph: (610) 447-6680 |
News Archive
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2013. For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012. Weighted average shares outstanding for the first quarters of 2013 and 2012 were 87.1 million and 71.4 million, respectively.
The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.
Levels of adherence to the UK's test, trace, and isolate system and understanding of the main symptoms of covid-19 are low, particularly among men, younger age groups, people with a dependent child in the home, key workers, and those experiencing greater financial hardship, finds an analysis of online survey data published by The BMJ today.
What if doctors could not only diagnose a COVID-19 infection but identify which patients are at the greatest risk of death before any major complications arise?
› Verified 2 days ago
Dr. Ezhilarasi Manickavasagam, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 2112 Sw H K Dodgen Loop Ste 110, Temple, TX 76504 Phone: 877-800-5722 | |
Dr. Madhava Reddy Beeram, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1901 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-935-4000 | |
Dr. Michael C. Smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Edwin Hernandez Caro, Pediatrics Medicare: Medicare Enrolled Practice Location: 1901 Sw H K Dodgen Loop Bldg 300, Temple, TX 76502 Phone: 254-724-5437 | |
Dr. Alisa Ana Acosta, MD, MPH Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Holly Mead Fatter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-5092 | |
Parneet Dhaliwal, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 South 31st Street, Ms-ck 300, Temple, TX 76508 Phone: 254-935-5063 |